000 01199 a2200313 4500
005 20250515202506.0
264 0 _c20100827
008 201008s 0 0 eng d
022 _a1742-7843
024 7 _a10.1111/j.1742-7843.2009.00514.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHeld, Thomas K
245 0 0 _aPharmacodynamic effects of haematopoietic cytokines: the view of a clinical oncologist.
_h[electronic resource]
260 _bBasic & clinical pharmacology & toxicology
_cMar 2010
300 _a210-4 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aClinical Trials as Topic
650 0 4 _aErythropoietin
_xadverse effects
650 0 4 _aGranulocyte Colony-Stimulating Factor
_xadverse effects
650 0 4 _aHematopoiesis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMedical Oncology
650 0 4 _aNeoplasms
_xblood
650 0 4 _aRecombinant Proteins
650 0 4 _aThrombopoietin
_xadverse effects
700 1 _aGundert-Remy, Ursula
773 0 _tBasic & clinical pharmacology & toxicology
_gvol. 106
_gno. 3
_gp. 210-4
856 4 0 _uhttps://doi.org/10.1111/j.1742-7843.2009.00514.x
_zAvailable from publisher's website
999 _c19430116
_d19430116